世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

カスタム抗体の世界市場:サービス別(抗体開発、抗体生産・精製、抗体断片化・標識)、タイプ別(モノクローナル抗体、ポリクローナル抗体、組み換え抗体、その他のカスタム抗体)、ソース別(マウス、ウサギ、その他のソース)、研究領域別(腫瘍学、感染症、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、受託研究機関)、地域別(北米、中南米、欧州、アジア太平洋、中東、アフリカ) - 2023年から2033年まで


Global Custom Antibody Market by Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling), by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies), by Source (Mice, Rabbit, and Other Sources), by Research Area (Oncology, Infectious Diseases, Neurobiology, Stem Cells, Immunology, Cardiovascular Disease, Other Research Areas) By End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), by Region (North America, Latin America, Europe, Asia- Pacific, Middle East, and Africa) - 2023 to 2033

カスタム抗体市場 - レポートのスコープ TMRの調査レポート「世界のカスタム抗体市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2023年3月20日 US$5,795
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
270 英語

このレポートは受注生産にて作成するため
通常よりご納品にお時間をいただく場合がございます。


 

サマリー

カスタム抗体市場 - レポートのスコープ
TMRの調査レポート「世界のカスタム抗体市場」は、2023年から2033年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2033年を予測年として考え、2017年から2033年までの期間における世界のカスタム抗体市場の収益を提供します。また、2023年から2033年までの世界のカスタム抗体市場の複合年間成長率(CAGR %)を掲載しています。

本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査の大部分を行った。二次調査では、カスタム抗体市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、および関連文書を参照した。

また、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体なども二次調査の対象とした。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界のカスタム抗体市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、世界のカスタム抗体市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場関係者だけでなく、世界のカスタム抗体市場への参入を検討している企業にとっても貴重なツールになります。

本レポートは、世界のカスタム抗体市場の競争環境について掘り下げています。世界のカスタム抗体市場で事業を展開する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のカスタム抗体市場のプレーヤーの属性です。

カスタム抗体の世界市場レポートで回答された主要な質問
- 予測期間中、全地域におけるカスタム抗体の売上/収益はどの程度か?
- 世界のカスタム抗体市場におけるビジネスチャンスは何か?
- 市場における主な促進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大するのはどの地域市場か?
- 2033年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか?
- 世界市場で事業を展開するさまざまな企業の市場ポジションはどのようなものか?

カスタム抗体市場 - 研究目的と研究アプローチ
カスタム抗体の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本調査の目的、市場で活動する主要ベンダーや流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。

読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。

本レポートでは、世界のカスタム抗体市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2033年末時点の各セグメントごとの市場シェアを提示しています。このような貴重な洞察により、市場関係者は、世界のカスタム抗体市場への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033
        5.3.1. Antibody Development
        5.3.2. Antibody Production & Purification
        5.3.3. Antibody Fragmentation & Labeling
    5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Service, 2023-2033
6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
        6.3.1. Monoclonal Antibodies
        6.3.2. Polyclonal Antibodies
        6.3.3. Recombinant Antibodies
        6.3.4. Other Custom Antibodies
    6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Type, 2023-2033
7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
        7.3.1. Mice
        7.3.2. Rabbits
        7.3.3. Other Sources
    7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
    7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033
        8.3.1. Oncology
        8.3.2. Infectious Diseases
        8.3.3. Neurobiology
        8.3.4. Stem Cells
        8.3.5. Immunology
        8.3.6. Cardiovascular Disease
        8.3.7. Other Research Areas
    8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022
    8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033
9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
        9.3.1. Pharmaceutical & Biotechnology Companies
        9.3.2. Academic & Research Institutes
        9.3.3. Contract Research Organizations
    9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
    9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    10.1. Introduction
    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific
        10.3.5. Middle East and Africa
    10.4. Market Attractiveness Analysis By Region
11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        11.2.1. By Country
            11.2.1.1. U.S.
            11.2.1.2. Canada
        11.2.2. By Service
        11.2.3. By Type
        11.2.4. By Source
        11.2.5. By Research Area
        11.2.6. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Service
        11.3.3. By Type
        11.3.4. By Source
        11.3.5. By Research Area
        11.3.6. By End User
    11.4. Key Takeaways
12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. Brazil
            12.2.1.2. Mexico
            12.2.1.3. Rest of Latin America
        12.2.2. By Service
        12.2.3. By Type
        12.2.4. By Source
        12.2.5. By Research Area
        12.2.6. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Service
        12.3.3. By Type
        12.3.4. By Source
        12.3.5. By Research Area
        12.3.6. By End User
    12.4. Key Takeaways
13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        13.2.1. By Country
            13.2.1.1. U.K.
            13.2.1.2. Spain
            13.2.1.3. Germany
            13.2.1.4. Italy
            13.2.1.5. France
            13.2.1.6. Rest of Europe
        13.2.2. By Service
        13.2.3. By Type
        13.2.4. By Source
        13.2.5. By Research Area
        13.2.6. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Service
        13.3.3. By Type
        13.3.4. By Source
        13.3.5. By Research Area
        13.3.6. By End User
    13.4. Key Takeaways
14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. India
            14.2.1.4. Rest of Asia Pacific
        14.2.2. By Service
        14.2.3. By Type
        14.2.4. By Source
        14.2.5. By Research Area
        14.2.6. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Service
        14.3.3. By Type
        14.3.4. By Source
        14.3.5. By Research Area
        14.3.6. By End User
    14.4. Key Takeaways
15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        15.2.1. By Country
            15.2.1.1. South Africa
            15.2.1.2. GCC Countries
            15.2.1.3. Rest of Middle East and Africa
        15.2.2. By Service
        15.2.3. By Type
        15.2.4. By Source
        15.2.5. By Research Area
        15.2.6. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Service
        15.3.3. By Type
        15.3.4. By Source
        15.3.5. By Research Area
        15.3.6. By End User
    15.4. Key Takeaways
16. Key Countries Custom Antibody Market Analysis
    16.1. U.S.
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Service
            16.1.2.2. By Type
            16.1.2.3. By Source
            16.1.2.4. By Research Area
            16.1.2.5. By End User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Service
            16.2.2.2. By Type
            16.2.2.3. By Source
            16.2.2.4. By Research Area
            16.2.2.5. By End User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Service
            16.3.2.2. By Type
            16.3.2.3. By Source
            16.3.2.4. By Research Area
            16.3.2.5. By End User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Service
            16.4.2.2. By Type
            16.4.2.3. By Source
            16.4.2.4. By Research Area
            16.4.2.5. By End User
    16.5. U.K.
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Service
            16.5.2.2. By Type
            16.5.2.3. By Source
            16.5.2.4. By Research Area
            16.5.2.5. By End User
    16.6. Spain
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Service
            16.6.2.2. By Type
            16.6.2.3. By Source
            16.6.2.4. By Research Area
            16.6.2.5. By End User
    16.7. Germany
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Service
            16.7.2.2. By Type
            16.7.2.3. By Source
            16.7.2.4. By Research Area
            16.7.2.5. By End User
    16.8. Italy
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Service
            16.8.2.2. By Type
            16.8.2.3. By Source
            16.8.2.4. By Research Area
            16.8.2.5. By End User
    16.9. France
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Service
            16.9.2.2. By Type
            16.9.2.3. By Source
            16.9.2.4. By Research Area
            16.9.2.5. By End User
    16.10. China
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Service
            16.10.2.2. By Type
            16.10.2.3. By Source
            16.10.2.4. By Research Area
            16.10.2.5. By End User
    16.11. Japan
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Service
            16.11.2.2. By Type
            16.11.2.3. By Source
            16.11.2.4. By Research Area
            16.11.2.5. By End User
    16.12. India
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Service
            16.12.2.2. By Type
            16.12.2.3. By Source
            16.12.2.4. By Research Area
            16.12.2.5. By End User
    16.13. South Africa
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Service
            16.13.2.2. By Type
            16.13.2.3. By Source
            16.13.2.4. By Research Area
            16.13.2.5. By End User
    16.14. GCC Countries
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Service
            16.14.2.2. By Type
            16.14.2.3. By Source
            16.14.2.4. By Research Area
            16.14.2.5. By End User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Service
        17.3.3. By Type
        17.3.4. By Source
        17.3.5. By Research Area
        17.3.6. By End User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Thermo Fisher Scientific
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. Bio-Rad Laboratories Inc.
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. Merck Group
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. Cell Signaling Technology, Inc.
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. GenScript
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. BioLegend
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. Abcam Plc
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Agilent Technologies
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Innovagen AB
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. Proteogenix
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
        18.1.11. Bio-Techne
            18.1.11.1. Overview
            18.1.11.2. Product Portfolio
            18.1.11.3. Profitability by Market Segments
            18.1.11.4. Sales Footprint
            18.1.11.5. Strategy Overview
                18.1.11.5.1. Marketing Strategy
        18.1.12. Creative Diagnostics
            18.1.12.1. Overview
            18.1.12.2. Product Portfolio
            18.1.12.3. Profitability by Market Segments
            18.1.12.4. Sales Footprint
            18.1.12.5. Strategy Overview
                18.1.12.5.1. Marketing Strategy
        18.1.13. Sino Biological, Inc.
            18.1.13.1. Overview
            18.1.13.2. Product Portfolio
            18.1.13.3. Profitability by Market Segments
            18.1.13.4. Sales Footprint
            18.1.13.5. Strategy Overview
                18.1.13.5.1. Marketing Strategy
        18.1.14. Raybiotech, Inc.
            18.1.14.1. Overview
            18.1.14.2. Product Portfolio
            18.1.14.3. Profitability by Market Segments
            18.1.14.4. Sales Footprint
            18.1.14.5. Strategy Overview
                18.1.14.5.1. Marketing Strategy
        18.1.15. ProSci Incorporated
            18.1.15.1. Overview
            18.1.15.2. Product Portfolio
            18.1.15.3. Profitability by Market Segments
            18.1.15.4. Sales Footprint
            18.1.15.5. Strategy Overview
                18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology

ページTOPに戻る



図表リスト

List of Tables

Table 1: Global Custom Antibody Market Value (US$ Million) Forecast by Region, 2018-2033

Table 2: Global Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 3: Global Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 4: Global Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 5: Global Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 6: Global Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 7: North America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 8: North America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 9: North America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 10: North America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 11: North America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 12: North America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 13: Latin America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 14: Latin America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 15: Latin America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 16: Latin America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 17: Latin America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 18: Latin America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 19: Europe Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 20: Europe Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 21: Europe Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 22: Europe Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 23: Europe Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 24: Europe Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 25: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 26: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 27: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 28: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 29: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 30: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 31: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 32: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 33: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 34: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 35: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 36: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

 

ページTOPに戻る


 

Summary

Custom Antibody Market – Scope of Report
TMR’s report on the global custom antibody market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global custom antibody market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global custom antibody market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the custom antibody market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global custom antibody market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global custom antibody market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global custom antibody market.

The report delves into the competitive landscape of the global custom antibody market. Key players operating in the global custom antibody market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global custom antibody market profiled in this report.

Key Questions Answered in Global Custom Antibody Market Report
• What is the sales/revenue generated by custom antibody across all regions during the forecast period?
• What are the opportunities in the global custom antibody market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Custom Antibody Market – Research Objectives and Research Approach
The comprehensive report on the global custom antibody market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global custom antibody market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global custom antibody market.



ページTOPに戻る


Table of Contents

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033
        5.3.1. Antibody Development
        5.3.2. Antibody Production & Purification
        5.3.3. Antibody Fragmentation & Labeling
    5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Service, 2023-2033
6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
        6.3.1. Monoclonal Antibodies
        6.3.2. Polyclonal Antibodies
        6.3.3. Recombinant Antibodies
        6.3.4. Other Custom Antibodies
    6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Type, 2023-2033
7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
        7.3.1. Mice
        7.3.2. Rabbits
        7.3.3. Other Sources
    7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
    7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033
        8.3.1. Oncology
        8.3.2. Infectious Diseases
        8.3.3. Neurobiology
        8.3.4. Stem Cells
        8.3.5. Immunology
        8.3.6. Cardiovascular Disease
        8.3.7. Other Research Areas
    8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022
    8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033
9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
        9.3.1. Pharmaceutical & Biotechnology Companies
        9.3.2. Academic & Research Institutes
        9.3.3. Contract Research Organizations
    9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
    9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    10.1. Introduction
    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific
        10.3.5. Middle East and Africa
    10.4. Market Attractiveness Analysis By Region
11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        11.2.1. By Country
            11.2.1.1. U.S.
            11.2.1.2. Canada
        11.2.2. By Service
        11.2.3. By Type
        11.2.4. By Source
        11.2.5. By Research Area
        11.2.6. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Service
        11.3.3. By Type
        11.3.4. By Source
        11.3.5. By Research Area
        11.3.6. By End User
    11.4. Key Takeaways
12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. Brazil
            12.2.1.2. Mexico
            12.2.1.3. Rest of Latin America
        12.2.2. By Service
        12.2.3. By Type
        12.2.4. By Source
        12.2.5. By Research Area
        12.2.6. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Service
        12.3.3. By Type
        12.3.4. By Source
        12.3.5. By Research Area
        12.3.6. By End User
    12.4. Key Takeaways
13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        13.2.1. By Country
            13.2.1.1. U.K.
            13.2.1.2. Spain
            13.2.1.3. Germany
            13.2.1.4. Italy
            13.2.1.5. France
            13.2.1.6. Rest of Europe
        13.2.2. By Service
        13.2.3. By Type
        13.2.4. By Source
        13.2.5. By Research Area
        13.2.6. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Service
        13.3.3. By Type
        13.3.4. By Source
        13.3.5. By Research Area
        13.3.6. By End User
    13.4. Key Takeaways
14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. India
            14.2.1.4. Rest of Asia Pacific
        14.2.2. By Service
        14.2.3. By Type
        14.2.4. By Source
        14.2.5. By Research Area
        14.2.6. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Service
        14.3.3. By Type
        14.3.4. By Source
        14.3.5. By Research Area
        14.3.6. By End User
    14.4. Key Takeaways
15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        15.2.1. By Country
            15.2.1.1. South Africa
            15.2.1.2. GCC Countries
            15.2.1.3. Rest of Middle East and Africa
        15.2.2. By Service
        15.2.3. By Type
        15.2.4. By Source
        15.2.5. By Research Area
        15.2.6. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Service
        15.3.3. By Type
        15.3.4. By Source
        15.3.5. By Research Area
        15.3.6. By End User
    15.4. Key Takeaways
16. Key Countries Custom Antibody Market Analysis
    16.1. U.S.
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Service
            16.1.2.2. By Type
            16.1.2.3. By Source
            16.1.2.4. By Research Area
            16.1.2.5. By End User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Service
            16.2.2.2. By Type
            16.2.2.3. By Source
            16.2.2.4. By Research Area
            16.2.2.5. By End User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Service
            16.3.2.2. By Type
            16.3.2.3. By Source
            16.3.2.4. By Research Area
            16.3.2.5. By End User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Service
            16.4.2.2. By Type
            16.4.2.3. By Source
            16.4.2.4. By Research Area
            16.4.2.5. By End User
    16.5. U.K.
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Service
            16.5.2.2. By Type
            16.5.2.3. By Source
            16.5.2.4. By Research Area
            16.5.2.5. By End User
    16.6. Spain
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Service
            16.6.2.2. By Type
            16.6.2.3. By Source
            16.6.2.4. By Research Area
            16.6.2.5. By End User
    16.7. Germany
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Service
            16.7.2.2. By Type
            16.7.2.3. By Source
            16.7.2.4. By Research Area
            16.7.2.5. By End User
    16.8. Italy
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Service
            16.8.2.2. By Type
            16.8.2.3. By Source
            16.8.2.4. By Research Area
            16.8.2.5. By End User
    16.9. France
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Service
            16.9.2.2. By Type
            16.9.2.3. By Source
            16.9.2.4. By Research Area
            16.9.2.5. By End User
    16.10. China
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Service
            16.10.2.2. By Type
            16.10.2.3. By Source
            16.10.2.4. By Research Area
            16.10.2.5. By End User
    16.11. Japan
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Service
            16.11.2.2. By Type
            16.11.2.3. By Source
            16.11.2.4. By Research Area
            16.11.2.5. By End User
    16.12. India
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Service
            16.12.2.2. By Type
            16.12.2.3. By Source
            16.12.2.4. By Research Area
            16.12.2.5. By End User
    16.13. South Africa
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Service
            16.13.2.2. By Type
            16.13.2.3. By Source
            16.13.2.4. By Research Area
            16.13.2.5. By End User
    16.14. GCC Countries
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Service
            16.14.2.2. By Type
            16.14.2.3. By Source
            16.14.2.4. By Research Area
            16.14.2.5. By End User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Service
        17.3.3. By Type
        17.3.4. By Source
        17.3.5. By Research Area
        17.3.6. By End User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Thermo Fisher Scientific
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. Bio-Rad Laboratories Inc.
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. Merck Group
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. Cell Signaling Technology, Inc.
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. GenScript
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. BioLegend
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. Abcam Plc
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Agilent Technologies
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Innovagen AB
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. Proteogenix
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
        18.1.11. Bio-Techne
            18.1.11.1. Overview
            18.1.11.2. Product Portfolio
            18.1.11.3. Profitability by Market Segments
            18.1.11.4. Sales Footprint
            18.1.11.5. Strategy Overview
                18.1.11.5.1. Marketing Strategy
        18.1.12. Creative Diagnostics
            18.1.12.1. Overview
            18.1.12.2. Product Portfolio
            18.1.12.3. Profitability by Market Segments
            18.1.12.4. Sales Footprint
            18.1.12.5. Strategy Overview
                18.1.12.5.1. Marketing Strategy
        18.1.13. Sino Biological, Inc.
            18.1.13.1. Overview
            18.1.13.2. Product Portfolio
            18.1.13.3. Profitability by Market Segments
            18.1.13.4. Sales Footprint
            18.1.13.5. Strategy Overview
                18.1.13.5.1. Marketing Strategy
        18.1.14. Raybiotech, Inc.
            18.1.14.1. Overview
            18.1.14.2. Product Portfolio
            18.1.14.3. Profitability by Market Segments
            18.1.14.4. Sales Footprint
            18.1.14.5. Strategy Overview
                18.1.14.5.1. Marketing Strategy
        18.1.15. ProSci Incorporated
            18.1.15.1. Overview
            18.1.15.2. Product Portfolio
            18.1.15.3. Profitability by Market Segments
            18.1.15.4. Sales Footprint
            18.1.15.5. Strategy Overview
                18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology

ページTOPに戻る



List of Tables/Graphs

List of Tables

Table 1: Global Custom Antibody Market Value (US$ Million) Forecast by Region, 2018-2033

Table 2: Global Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 3: Global Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 4: Global Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 5: Global Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 6: Global Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 7: North America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 8: North America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 9: North America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 10: North America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 11: North America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 12: North America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 13: Latin America Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 14: Latin America Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 15: Latin America Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 16: Latin America Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 17: Latin America Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 18: Latin America Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 19: Europe Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 20: Europe Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 21: Europe Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 22: Europe Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 23: Europe Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 24: Europe Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 25: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 26: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 27: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 28: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 29: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 30: Asia Pacific Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

Table 31: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Country, 2018-2033

Table 32: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Service, 2018-2033

Table 33: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Type, 2018-2033

Table 34: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Source , 2018-2033

Table 35: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by Research Area, 2018-2033

Table 36: Middle East and Africa Custom Antibody Market Value (US$ Million) Forecast by End User, 2018-2033

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Transparency Market Research 社の最新刊レポート

本レポートと同じKEY WORD(oncology)の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/17 10:30

141.77 円

158.05 円

189.84 円

ページTOPに戻る